Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Incannex Healthcare Inc. before investing.

In this article, we go over a few key elements for understanding Incannex Healthcare Inc.’s stock price such as:

• Incannex Healthcare Inc.’s current stock price and volume
• Why Incannex Healthcare Inc.’s stock price changed recently
• Upgrades and downgrades for IXHL from analysts
• IXHL’s stock price momentum as measured by its relative strength

About Incannex Healthcare Inc. (IXHL)

Before we jump into Incannex Healthcare Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn’s disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.

Want to learn more about Incannex Healthcare Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Incannex Healthcare Inc..

Incannex Healthcare Inc.’s Stock Price as of Market Close

As of April 24, 2026, 10:47 AM, CST, Incannex Healthcare Inc.’s stock price was $3.920.

Incannex Healthcare Inc. is up 3.43% from its previous closing price of $3.790.

During the last market session, Incannex Healthcare Inc.’s stock traded between $3.630 and $4.000. Currently, there are approximately 11.65 million shares outstanding for Incannex Healthcare Inc..

Incannex Healthcare Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Incannex Healthcare Inc. Stock Price History

Incannex Healthcare Inc.’s (IXHL) price is currently up 30.67% so far this month.

During the month of April, Incannex Healthcare Inc.’s stock price has reached a high of $4.250 and a low of $2.490.

Over the last year, Incannex Healthcare Inc. has hit prices as high as $49.800 and as low as $2.400. Year to date, Incannex Healthcare Inc.’s stock is down 63.5%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Incannex Healthcare Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 23, 2026, there were analysts who downgraded Incannex Healthcare Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Incannex Healthcare Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Incannex Healthcare Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Incannex Healthcare Inc. (IXHL) by visiting AAII Stock Evaluator.

Relative Price Strength of Incannex Healthcare Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 23, 2026, Incannex Healthcare Inc. has a weighted four-quarter relative price strength of -15.90%, which translates to a Momentum Score of 15 and is considered to be Very Weak.

Want to learn more about how Incannex Healthcare Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Incannex Healthcare Inc. Stock Price: Bottom Line

As of April 24, 2026, Incannex Healthcare Inc.’s stock price is $3.920, which is up 3.43% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Incannex Healthcare Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.